Introduction {#Sec1}
============

The prevalence of bacterial infections is one of the main reasons of mortality in hemodialysis patients. In fact, the weakened immune system and nature of dialysis devices predispose hemodialysis patients for infection. Based on recent reports, *Staphylococcus (S.) aureus* is the most prevalent bacterial infection in hemodialysis individuals ranging from minor skin infections to serious infections including bacteremia, osteomyelitis, necrotizing pneumonia, infective endocarditis, and toxic shock syndrome (TSS) \[[@CR1]\]. It is capable of colonization in the different sites of body such axillary, perineal and nasal (nasal carriage of *S. aureus*) \[[@CR2], [@CR3]\].

The nasal carriage of *S. aureus* is not often the main cause of infection however it can act as a reservoir for subsequent infections in individuals colonized with this pathogen \[[@CR4], [@CR5]\].

At present, the emergence of antibiotic resistant *S. aureus* strains known as methicillin-resistant *S. aureus* (MRSA) has become a serious menace in hospital and community settings. The MRSA infections are mainly associated with increasing morbidity and mortality and length of hospital stay especially in individuals with cancer, HIV, diabetes, rheumatoid arthritis and patients undergoing dialysis \[[@CR1]\].

The origin of *S. aureus* infections in dialysis patients is mostly related to *S. aureus* nasal carriage. This microorganism is transmitted from the nasal reservoir to the hands and skin, and then to the access. So, the prevention of colonization of *S. aureus* can be an effective method to infection control in hemodialysis patients. This study was aimed to examine prevalence of MRSA colonization in hemodialysis patients as a main cause of infection and mortality in hemodialysis population.

Main text {#Sec2}
=========

Methods {#Sec3}
-------

### Sample collection {#Sec4}

The swab samples were collected from hemodialysis patients referred to the Imam Reza hospital of Tabriz, Iran from July 6, 2018 to August 6, 2018. The samples were obtained from three different sites including nasal, throat and skin around the catheter. Patients' clinical data including gender, age and clinical conditions were recorded before samples collection. The relationship between *S. aureus* carriage and clinical conditions of hemodialysis patients such as hypertension, diabetes mellitus, glomerulonephritis, lupus, familial Mediterranean fever, polycystic kidney, cardiovascular, pulmonary infections and length of hospitalization, the effect of risk factors such smoking was also examined. The procedures followed were according to the ethical standards of the committee on human experimentation of our institution.

### Bacteria identification {#Sec5}

The samples were cultured in selective media (Manitol Salt agar and blood agar media) and incubated overnight at 37 °C. The *S. aureus* isolates were identified based on conventional microbiological and biochemical tests (Gram-staining, colony morphology, coagulase test (coagulase was positive for *S. aureus*) and catalase test \[[@CR6]\].

### Antimicrobial susceptibility testing {#Sec6}

The susceptibility pattern of isolates to various antibiotics was determined by Kirby Bauer disk diffusion testing based on the Clinical Laboratory Standards Institute (CLSI) guidelines \[[@CR7]\]. Antibiotic disks used were as follow: oxacillin (1 μg), mupirocin (10 μg), rifampicin (5 μg), erythromycin (15 μg), clindamycin (2 μg), minocycline (30 μg), linezolid (30 μg), cefazolin (30 μg), and trimethoprim-sulfamethoxsazole (1.25/23.75 µg), ampicillin (5 μg), cefoxitin (30 μg), novobiocin (5 μg). Muller--Hinton agar plats were used for susceptibility tests and the bacterial concentrations for inoculation of plates were equal to 0.5 McFarland. The disks were incubated with the inoculated plates at 37 °C overnight. Based on CLSI guideline, *S. aureus* ATCC 25923 (methicillin susceptible) and *S aureus* ATCC 33591 (methicillin resistant) were used as positive control and ultrapure water was as negative control.

### Statistical analysis {#Sec7}

Statistical analysis was carried out by the SPSS version 16. Demographic and clinical variables were compared by Chi square test (*p* \< 0.05).

Results {#Sec8}
-------

### Bacterial identification {#Sec9}

A total of 560 samples from nasal, throat and skin around the catheter were obtained from 231 hemodialysis patients. A total of 166 *S. aureus* isolates (29.64%) were isolated from 560 samples which 62.04% (103/166) of *S. aureus* isolates were MRSA. Totally, from 231 patients, 118 individuals (50.65%) were identified as *S. aureus* carriage which 67.79% (80/118) of them were MRSA carriers. There was no significant difference in the prevalence of MRSA among hemodialysis patients with history of past illness. Demographic data of patients including gender, age, risk factors, illness history and the types of collected clinical specimens were summarized in Table [1](#Tab1){ref-type="table"}. According to statistical analysis results, the frequency of MRSA is independent on gender (*p* = 0.302). But, it was dependent on sampling site so that prevalence of MRSA was significantly higher in nasal samples (30.70%) (*p* \< 0.00001). *S. aureus* colonization in the absence of nasal colonization was observed in 12.71% (15/118) patients. Based on results, frequency of MRSA colonization was dependent on type of vascular access used in hemodialysis patients (*p* = 0.032) so that 44.06% of MRSA carriers were related to hemodialysis patients with a catheter.Table 1Demographic data of hemodialysis patients admitted to Imam Reza hospital of TabrizStudy group (n = 231)MRSAMSSA*p* valueGender Female (n = 86)35150.302 Male (n = 145)4523Age 17--30 (n = 21)270.0522 31--40 (n = 15)620.35238 41--50 (n = 27)1080.846755 51--60 (n = 56)20110.891901 \> 60 (n = 110)37150.832589Samples (n = 560) Nasal (s = 228)7037\< 0.00001 Trout (s = 225)1511 Around catheter (s = 114)1814Vascular access for dialysis Catheter (n = 116)52160.030, \< 0.05 Fistula (n = 115)2921Illness history Hypertension (n = 129)50200.299 Diabetes mellitus (n = 102)31180.399 Glomerulonephritis (n = 10)420.95 Polycystic kidney (n = 11)430.336 Pulmonary infections (n = 6)210.962 Cardiovascular (n = 22)930.555 Familial Mediterranean fever (n = 1)110.761 Lupus (n = 2)200.259 Length of hospitalization (27)1160.627 Smoking (17)450.118 Antibiotic consumption (n = 34)1450.562n, number of patients; s, number of samples

### Antimicrobial susceptibility {#Sec10}

Antibiotic resistance profile to 11 antibiotics was determined on 166 *S. aureus* isolates by the disc diffusion agar. The highest antibiotic resistance rate was observed against Ampicillin (93.98%) and the highest sensitivity was against linezolid antibiotic disk (5.42%). However, based on CLSI guideline, intermediate sensitivity values to linezolid was not reported. Based on results of resistance to cefoxitin, 34.93% (80/231) of patients were MRSA carriage. Details of results of the disc diffusion test are shown in Fig. [1](#Fig1){ref-type="fig"}. Out of the 166 *S. aureus* isolates, 90 (54.22%) isolates including 58 (34.94%) nasal, 16 (9.64%) catheter, 16 (9.64%) throat showed multi-drug resistant property (MDR) based on resistance to three or more classes of antibiotic \[[@CR8]\] and 2 isolates (1.2%) were resistant to all of antibiotics.Fig. 1Results of antibiotic susceptibility test of *S. aureus* strains isolated from hemodialysis patients

Discussion {#Sec11}
----------

At present, increasing prevalence of MRSA infections has become a serious issue in clinical settings due to MRSAs are resistant to most of antibiotic classes especially β-lactams \[[@CR9]\]. According to researches done, there is a direct relationship between *S. aureus* colonization and incidence of infection \[[@CR10], [@CR11]\]. In the present study, *S. aureus* colonization was detected in 50.65% of hemodialysis patients that 67.79% of *S. aureus* isolates were found as MRSA and totally 34.93% of patients were identified as MRSA carriage. In a study conducted in north of Iran, 36.9% of hemodialysis patients were found as *S aureus* carriage which MRSA colonization was detected in 74.2% of *S. aureus* carriers \[[@CR12]\]. But, in a study carried out on hemodialysis patients in South of Iran, only 19.67% of individuals, were carriers of S. aureus and 6.56% were MRSA carriage \[[@CR13]\]. The rate of *S. aureus* colonization at nasal, throat and catheter around was documented in 30.78%, 6.66% and 15.78% of hemodialysis patients while in one report offered from north of Iran, 36.9% of hemodialysis patients were *S. aureus* nasal carriage \[[@CR12]\].

Also, in another study carried out by Devraj et al. *S. aureus* colonization in throat were observed in 11.4% of hemodialysis patients \[[@CR14]\].

In our study, 44.06% of MRSA carriers were related to hemodialysis patients using from a catheter. In this respect, researches showed that the possibility of infection in patients with catheter is two- to threefold higher than individuals with a fistula or graft \[[@CR15]\].

In the present study, 25% of *S. aureus* isolates were resistant to Clindamycin, consistent with results obtained from south of IRAN \[[@CR13]\]. Also, 6.63% of *S. aureus* isolates were resistant to Rifampicin similar with study carried out in Mashhad, Iran \[[@CR16]\].

In this study, there was no significant difference in the prevalence of MRSA colonization among hemodialysis patients with past illness history. These results were consistent with the similar results regarding lack of relationship between *S. aureus* colonization and clinical conditions of hemodialysis patients such as diabetes and Hypertension \[[@CR12], [@CR14]\]. In the present study, MRSA colonization was independent of age consistent with similar studies \[[@CR17], [@CR18]\].

Although, *S. aureus* colonization is often detected in nasal, there are evidences regarding extra nasal *S. aureus* colonization in patients \[[@CR19], [@CR20]\]. Our results are indicating incidence of 12.711% extranasal *S. aureus* colonization without nasal colonization in patients that is similar to results of Zahed et al. conducted in Tehran, Iran regarding incidence of 12% extranasal *S. aureus* colonization in hemodialysis patients \[[@CR21]\].

Conclusion {#Sec12}
----------

Our results were indicating incidence of nasal and extranasal MRSA colonization in hemodialysis patients in the study region. These findings highlight the necessity of prophylaxis against *S. aureus* in individuals under dialysis.

Limitations {#Sec13}
===========

Since, the conventional biochemical tests are not definitive and can misidentify *S. aureus* isolates so PCR method can be used for confirmation of *S. aureus* and MRSA isolates.

MRSA

:   methicillin resistant *Staphylococcus (S.) aureus*

TSS

:   toxic shock syndrome

MDR

:   multi-drug resistant
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